These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6025774)

  • 1. Polymorphism and drug availability. II. Dissolution rate behavior of the polymorphic forms of sulfathiazole and methylprednisolone.
    Higuchi WI; Bernardo PD; Mehta SC
    J Pharm Sci; 1967 Feb; 56(2):200-7. PubMed ID: 6025774
    [No Abstract]   [Full Text] [Related]  

  • 2. Rate of crystal growth of sulfathiazole and methylprednisolone.
    Mehta SC; Bernardo PD; Higuchi WI; Simonelli AP
    J Pharm Sci; 1970 May; 59(5):638-44. PubMed ID: 5446419
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissolution rates of high energy sulfathiazole--povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies.
    Simonelli AP; Mehta SC; Higuchi WI
    J Pharm Sci; 1976 Mar; 65(3):355-61. PubMed ID: 1263082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution studies of povidone-sulfathiazole coacervated systems.
    Badawi AA; El-Sayed AA
    J Pharm Sci; 1980 May; 69(5):492-7. PubMed ID: 7381728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the onset of crystallization of N1-2-(thiazolyl)sulfanilamide (sulfathiazole) by UV-Vis and calorimetry using an automated reaction platform; subsequent characterization of polymorphic forms using dispersive Raman spectroscopy.
    Anderson JE; Moore S; Tarczynski F; Walker D
    Spectrochim Acta A Mol Biomol Spectrosc; 2001 Aug; 57(9):1793-808. PubMed ID: 11506030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser Raman investigation of drug-polymer conjugates: sulfathiazole-povidone coprecipitates.
    Bolton BA; Prasad PN
    J Pharm Sci; 1984 Dec; 73(12):1849-51. PubMed ID: 6527275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of dissolution rates of poorly water-soluble drugs by crystallization in aqueous surfactant solutions I: Sulfathiazole, prednisone, and chloramphenicol.
    Chiou WL; Chen SJ; Athanikar N
    J Pharm Sci; 1976 Nov; 65(11):1702-4. PubMed ID: 994008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Batch cooling crystallization and pressure filtration of sulphathiazole: the influence of solvent composition.
    Häkkinen A; Pöllänen K; Karjalainen M; Rantanen J; Louhi-Kultanen M; Nyström L
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):17-28. PubMed ID: 15283678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polyethylene glycol 4000 on dissolution properties of sulfathiazole polymorphs.
    Niazi S
    J Pharm Sci; 1976 Feb; 65(2):302-4. PubMed ID: 1255470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the riddle of sulfathiazole polymorphism.
    Abu Bakar MR; Nagy ZK; Rielly CD; Dann SE
    Int J Pharm; 2011 Jul; 414(1-2):86-103. PubMed ID: 21596117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinylsulfathiazole crystal forms. I. Preparation, characterization, and interconversion of different crystal forms.
    Moustafa MA; Khalil SA; Ebian AR; Motawi MM
    J Pharm Sci; 1974 Jul; 63(7):1103-9. PubMed ID: 4854519
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES ON THE MOLECULAR COMPOUNDS OF ORGANIC MEDICINALS. I. DISSOLUTION BEHAVIOR OF THE MOLECULAR COMPOUNDS OF SULFANILAMIDE AND SULFATHIAZOLE.
    SEKIGUCHI K; ITO K
    Chem Pharm Bull (Tokyo); 1965 Apr; 13():405-13. PubMed ID: 14294833
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymorph farming of acetaminophen and sulfathiazole on a chip.
    Lee T; Hung ST; Kuo CS
    Pharm Res; 2006 Nov; 23(11):2542-55. PubMed ID: 16969701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The recrystallization and dissolution of acetylsalicylic acid.
    Jamali F; Mitchell AG
    Acta Pharm Suec; 1973 Sep; 10(4):343-52. PubMed ID: 4759360
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
    Tran TT; Tran PH; Park JB; Lee BJ
    Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alcohol-partitioning type and airflow on cosolvent flooding to benzene-LNAPL saturated porous media.
    Jeong SW; Ju BK; Lee BJ
    J Hazard Mater; 2009 Jul; 166(2-3):603-11. PubMed ID: 19131164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical properties and controlled drug release of microcapsules prepared by simple coacervation.
    Shimokawa K; Saegusa K; Wada Y; Ishii F
    Colloids Surf B Biointerfaces; 2013 Apr; 104():1-4. PubMed ID: 23298580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heats of transition of methylprednisolone and sulfathiazole by a differential thermal analysis method.
    Guillory JK
    J Pharm Sci; 1967 Jan; 56(1):72-6. PubMed ID: 6030499
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibited dissolution of drug crystals by certified water-soluble dyes. II.
    Piccolo J; Tawashi R
    J Pharm Sci; 1971 Jan; 60(1):59-63. PubMed ID: 5548243
    [No Abstract]   [Full Text] [Related]  

  • 20. Crystal polymorphism of pharmaceuticals: probing crystal nucleation at the molecular level.
    Guiry KP; Kelleher JM; Lawrence SE; McAuliffe MT; Moynihan HA; Ryan AL
    J Enzyme Inhib Med Chem; 2007 Oct; 22(5):550-5. PubMed ID: 18035822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.